Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Spaner

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
European Review for Medical and Pharmacological Sciences|December 5, 2019
PPARγ inhibits breast cancer progression by upregulating PTPRF expressionY-Y Xu, H Liu, L Su, et al.
Seminars in Oncology|November 24, 1999
Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphomaR Buckstein, K Imrie, D Spaner, et al.
Bone Marrow Transplantation|February 13, 2002
Bcl-2 clearance: optimising outcomes in follicular non-Hodgkin's lymphomaN L Berinstein, R Buckstein, K Imrie, et al.
Bone Marrow Transplantation|January 23, 1999
Clinical and economic analysis of allogeneic peripheral blood progenitor cell transplants: a Canadian perspectiveS Couban, G Dranitsaris, P Andreou, et al.
Bone Marrow Transplantation|November 26, 2008
Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphomaL K Hicks, A Woods, R Buckstein, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
European Review for Medical and Pharmacological Sciences|December 5, 2019
PPARγ inhibits breast cancer progression by upregulating PTPRF expressionY-Y Xu, H Liu, L Su, et al.
Seminars in Oncology|November 24, 1999
Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphomaR Buckstein, K Imrie, D Spaner, et al.
Bone Marrow Transplantation|February 13, 2002
Bcl-2 clearance: optimising outcomes in follicular non-Hodgkin's lymphomaN L Berinstein, R Buckstein, K Imrie, et al.
Bone Marrow Transplantation|January 23, 1999
Clinical and economic analysis of allogeneic peripheral blood progenitor cell transplants: a Canadian perspectiveS Couban, G Dranitsaris, P Andreou, et al.
Bone Marrow Transplantation|November 26, 2008
Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphomaL K Hicks, A Woods, R Buckstein, et al.
Pageof 5